Integra LifeSciences is presenting its ENT and surgical instrument portfolio at the AAO-HNSF 2026 Annual Meeting in Los Angeles, highlighting innovations like the ACCLARENT AERA Eustachian Tube Balloon Dilation System. The company also sponsors new clinical research on Eustachian tube balloon dilation's impact on chronic ear disease surgery outcomes. This event underscores Integra's commitment to advancing ENT care through innovation and clinical evidence, with hands-on training available for attendees. The ACCLARENT AERA system recently gained FDA clearance for pediatric use, expanding treatment options for younger patients.
Integra LifeSciences and its ENT and surgical instrument portfolio are the focus, with Pluang's Health-sector market data providing context. For readers following Health-sector US stocks, here is Pluang's market snapshot as of Oct 16, 2026 19:01 WIB: out of 150 priced stocks, 93 rose and 46 fell. Notable movers include ACAD at USD 19.99 with a 1-day change of +1.42%, AMRX at USD 19.50 with +1.30%, and CGC at USD 0.74 with +1.29%.
Whole Lotta Dank, a Canadian cannabis brand platform, has launched its first brand, Dank Pack, debuting with Blueberry BBL available across Alberta. The company is expanding its portfolio with over 20 SKUs under regulatory review and is actively seek...
Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investor...
David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...
The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...
SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...
